Joe Walsh is the first Alzheimer’s patient to be treated with an experimental nasal spray designed to reduce inflammation in the brain.
Joe Walsh is the first Alzheimer’s patient to be treated with an experimental nasal spray designed to reduce inflammation in the brain.